As we enter an era of groundbreaking therapies for metabolic diseases, it's more important than ever to come together and tackle the emerging questions in drug development. To address these challenges, 8 leading pharmaceutical companies, 2 renowned academic institutions, and 2 regulatory agencies are joining forces for a one-day, one-of-a-kind workshop focused on metabolic disorders. STATBOLIC is a working group in ASA Biopharmaceutical Section.
This is a rare opportunity to collaborate, exchange insights, and help shape the future of drug development in this rapidly advancing field.
⏳ Seats are limited-don't miss out!
Register now using the link below:
STATBOLIC Registration - Biopharmaceutical Section (amstat.org)
------------------------------
Hiya Banerjee
Biostatistician
------------------------------